Immunoinformatics-guided design of a universal chimeric multi-epitope subunit vaccine against Marburg virus disease and Ravn virus co-infection

1. Kortepeter, M. G. et al. Marburg virus disease: a summary for clinicians. Int. J. Infect. Dis. 99, 233–242 (2020).

   Google Scholar 

2. Kuhn, J. H. et al. New filovirus disease classification and nomenclature. Nat. Rev. Microbiol. 17 (5), 261–263 (2019).

   Google Scholar 

3. Shifflett, K. & Marzi, A. Marburg virus pathogenesis: differences and similarities in humans and animal models. Virol. J. 16 (1), 165 (2019).

   Google Scholar 

4. World Health Organization. Marburg virus disease. (2025).

5. Pervin, T. & Oany, A. R. Vaccinomics approach for designing potential epitope-based peptide vaccine targeting L-protein of Marburg virus. Silico Pharmacol. 9 (1), 21 (2021).

   Google Scholar 

6. Islam, M. R., Akash, S., Rahman, M. M. & Sharma, R. Epidemiology, pathophysiology, transmission, genomic structure, treatment and future perspectives of the novel Marburg virus outbreak. Int. J. Surg. 109, 36–38 (2023).

   Google Scholar 

7. Stille, W. & Böhle, E. Clinical course and prognosis of Marburg virus (green-monkey) disease. In Marburg Virus Disease 10–18Springer, Berlin, Heidelberg, (1971).

8. Abdelrahman, A. H. et al. Exploration of African natural products as VP35 inhibitors to combat Marburg virus infection: molecular docking, molecular dynamics and quantum mechanical computations. PLoS One 20(10), e0334160 (2025).

9. Hasnain, A. et al. AI-driven in Silico discovery and design of antiviral candidates targeting Marburg virus nucleoprotein. Lett. Drug Des. Discov 22(3), 100030 (2025).

10. Jia, Y. et al. Sweet syndrome induced by SARS-CoV-2 vaccines: a systematic review of patient-report studies. Hum. Vaccin Immunother. 19, 2217076 (2023).

    Google Scholar 

11. Xu, K. et al. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt–Koyanagi–Harada disease. Hum. Vaccin Immunother. 19, 2220630 (2023).

    Google Scholar 

12. Kim, H. M. et al. Crystal structure of the TLR4–MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130, 906–917 (2007).

    Google Scholar 

13. Kim, J., Yang, Y. L., Jang, S. H. & Jang, Y. S. Human β-defensin 2 regulates innate antiviral immunity and potentiates antigen-specific immunity. Virol. J. 15 (1), 1–12 (2018).

    Google Scholar 

14. Salomon-Ferrer, R. et al. Routine microsecond molecular dynamics simulations with AMBER on gpus: explicit solvent particle mesh Ewald. J. Chem. Theory Comput. 9 (9), 3878–3888 (2013).

    Google Scholar 

15. Bhardwaj, V. K. & Purohit, R. Targeting the protein–protein interface pocket of the aurora-A–TPX2 complex: rational drug design and validation. J. Biomol. Struct. Dyn. 39 (11), 3882–3891 (2021).

    Google Scholar 

16. Roe, D. R. & Cheatham, T. E. PTRAJ and CPPTRAJ: software for processing and analyzing molecular dynamics trajectories. J. Chem. Theory Comput. 9 (7), 3084–3095 (2013).

    Google Scholar 

17. Wang, W. et al. Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments. Mil Med. Res. 12, 69 (2025).

    Google Scholar 

18. Zhang, H. Q. et al. An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination. Hum. Vaccin Immunother. 19, 2263229 (2023).

    Google Scholar 

19. Khan, A. et al. Immunogenomics-guided design of Immunomodulatory multi-epitope subunit vaccine against SARS-CoV-2 variants. Comput. Biol. Med. 133, 104420 (2021).

    Google Scholar 

20. Liu, B. et al. Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score). Sci. Rep. 12, 20002 (2022).

    Google Scholar 

21. Gasteiger, E. et al. Humana Press,. Protein identification and analysis tools on the ExPASy server. In The Proteomics Protocols Handbook 571–607 (2005).

22. Kawai, T. & Akira, S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17 (4), 338–344 (2005).

    Google Scholar 

23. Kawai, T. & Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2), 131–137 (2006).

    Google Scholar 

24. Pasare, C. & Medzhitov, R. Toll-like receptors: linking innate and adaptive immunity. Mech. Lymphocyte Activ Immune Regul. X, 11–18 (2005).

    Google Scholar 

25. Grote, A. et al. JCat: a tool for adapting codon usage to expression hosts. Nucleic Acids Res. 33, W526–W531 (2005).

    Google Scholar 

26. Kang, S. M. & Compans, R. W. Host responses from innate to adaptive immunity after vaccination. Mol. Cells. 27 (1), 5–14 (2009).

    Google Scholar 

Download references

Authors and Affiliations

1. School of Medical Sciences, Shandong Xiehe University, Jinan, 250109, P. R. China

   Sardar Ali

2. Department of Biochemistry, University of Veterinary and Animal Sciences Swat, Swat, KP, Pakistan

   Abdullah Shah

3. Department of Biotechnology, Shaheed Benazir Bhutto University, Sheringal, 18000, Pakistan

   Sikandar Khan

4. Biomedical Research Center, Qatar University, Doha, 2713, Qatar

   Muhammad Suleman

5. Department of Basic and Applied zoology, Shaheed Benazir Bhutto University, Sheringal, 18000, Pakistan

   Ziaul Islam

6. Department of Pharmacology, Shantou University Medical College, Shantou, 515041, China

   Muhammad Tahir Aleem

7. Center for Gene Regulation in Health and Disease, Department of Biological, Geological, and Environmental Sciences, College of Sciences and Health Professions, Cleveland State University, Cleveland, OH, 44115, USA

   Muhammad Tahir Aleem

Contributions

**S. Ali, A. Shah, M.T. Aleem, S. Khan: ** Conceptualization, **S. Ali, ** Writing-original draft, **S. Ali, M.T. Aleem, S. Khan: ** Formal analysis, **S. Ali, S. Khan, M.T. Aleem: ** Supervision, **M. Suleman, Z. Islam, S. Ali, A Shah, M.T. Aleem, S. Khan: ** Writing-review & editing, **S. Ali, S. Khan, M.T. Aleem, M. Suleman: ** Data curation, **A. Shah, M. Suleman, M.T. Aleem: ** Visualization, **M. Suleman, A. Shah, Z. Islam, S. Ali: ** Resources.

Corresponding authors

Correspondence to Sardar Ali or Muhammad Tahir Aleem.

Competing interests

The authors declare no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions